The primary 5 amino 1mq benefits include significant fat loss (particularly visceral fat), improved body composition without muscle loss, enhanced insulin sensitivity, increased cellular energy production, and support for healthy aging processes
PubMed (NIH/NLM) records related to this compound for laboratory literature review
Laboratory monitoring may include complete blood counts, comprehensive metabolic panels, and hepatic function tests, though specific monitoring protocols have not been established through clinical trials
SARM1 regulates NAD(+)-linked metabolism and select immune genes in macrophages
Each vial contains 5mg of TB-500 (Thymosin Beta-4 analogue) and 5mg of BPC-157 (Body Protection Compound-157), co-lyophilised into a single vial for research convenience
Observed in pilot human work A 2025 IV infusion pilot of BPC-157 in two adults at 10 mg and 20 mg reported no adverse effects on cardiac, hepatic, renal, thyroid, or glucose biomarkers (Lee et al., Alternative Therapies in Health and Medicine, 2025)